Amplio Pharma
Amplio Pharma is a pharmaceutical company that develops proprietary drug products that amplify the efficacy of pharmaceutical treatments.
Amplio Pharma is a company based in Lund, Sweden. Recent Funding lists it under Health and bio (also Manufacturing and industrial). It raised $400K in a Seed round in April 2025, according to startupintros.com. Its latest round on record is a Seed round in October 2026, amount undisclosed. Investors on record include Amsterdam UMC Ventures, Innovatiefonds Noord-Holland, LEH and ROM InWest. It was founded by Charlott Brunmark, Karin von Wachenfeldt and Marguérite Mensonides.
Funding rounds
- Seed · amount undisclosedSource: european-biotechnology.com
- Seed · $400KSource: startupintros.com
- Website created
Founders and team
CB
Charlott Brunmark FounderKV
Karin von Wachenfeldt FounderMM
Marguérite Mensonides Founder
Investors
Amplio Pharma: questions and answers
- How much has Amplio Pharma raised?
- Amplio Pharma has raised $400K in one sourced round on record (Seed), announced April 1, 2025.
- Who invested in Amplio Pharma?
- Investors on record for Amplio Pharma: Amsterdam UMC Ventures, Innovatiefonds Noord-Holland, LEH and ROM InWest.
- Who founded Amplio Pharma?
- Amplio Pharma was founded by Charlott Brunmark, Karin von Wachenfeldt and Marguérite Mensonides.
- Where is Amplio Pharma based?
- Amplio Pharma is based in Lund, Sweden.
Similar Health and bio companies
VVocca$20M Series A · Oct 2026
CCori Clinical$4M Seed · Oct 2026
SSunfox$7M Series A · Oct 2026AAlteogen$150M Series B+ · Oct 2026
Ccalliora$6M Pre Seed · Oct 2026
SSuperMush$3M Series A · Oct 2026
Every amount links to the page it came from. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/amplio-pharma.